GALAPAGOS NV (GLPG)

Sentiment-Signal

11,2
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
3.8
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)

Score-Verlauf (90 Tage)

Stammdaten

Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel CD, fistulizing CD, ankylosing spondylitis, psoriatic arthritis, and uveitis. The company's pipeline products also comprise GLPG1972 that has completed Phase 2b trial for treating osteoarthritis; Toledo molecules, including GLPG3970, GLPG4399, and GLPG4876 for inflammation; and GLPG4716 and Ziritaxestat to treat idiopathic pulmonary fibrosis. In addition, its other pipeline products include GLPG2737, a cystic fibrosis transmembrane conductance regulator that is in Phase 2 clinical trials to treat patients with autosomal dominant polycystic kidney disease; and GLPG0555, a JAK1 inhibitor, which is in Phase 1b for treatment of patients with osteoarthritis. The company has collaboration agreements with Gilead Sciences, Inc.; AbbVie S.à r.l.; and Novartis Pharma AG. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.

Unternehmen & Branche

NameGALAPAGOS NV
TickerGLPG
CIK0001421876
BoerseUS
SektorHealthcare
IndustrieBiotechnology
SIC2834 · Pharmaceutical Preparations

Wertpapier & Kennzahlen

CUSIP36315X101
ISINUS36315X1019
TypADR
Marktkapitalisierung1,93 Mrd. USD
Beta0,15
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Fondsaktivität (Vorquartalsvergleich)

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
GILEAD SCIENCES, INC.16,707,477016,707,477550,616,290Neu+100,0%
Madison Avenue Partners, LP2,213,16902,213,16972,370,626Neu+100,0%
AMERIPRISE FINANCIAL INC1,451,23901,451,23947,455,516Neu+100,0%
SEGALL BRYANT & HAMILL, LLC448,0960448,09614,652,739Neu+100,0%
UBS Group AG349,4440349,44411,426,819Neu+100,0%
MILLENNIUM MANAGEMENT LLC339,3540339,35411,096,876Neu+100,0%
BlackRock, Inc.314,2690314,26910,276,596Neu+100,0%
RENAISSANCE TECHNOLOGIES LLC310,6000310,60010,156,620Neu+100,0%
D. E. Shaw & Co., Inc.274,9990274,9998,992,467Neu+100,0%
Hudson Bay Capital Management LP170,0000170,0005,559,000Neu+100,0%
DAFNA Capital Management LLC130,1750130,1754,256,723Neu+100,0%
CITADEL ADVISORS LLC108,1960108,1963,538,010Neu+100,0%
NORGES BANK90,000090,0002,943,000Neu+100,0%
MORGAN STANLEY68,285068,2852,232,921Neu+100,0%
FMR LLC56,969056,9691,862,887Neu+100,0%
Man Group plc47,581047,5811,555,899Neu+100,0%
VOLORIDGE INVESTMENT MANAGEMENT, LLC43,856043,8561,434,091Neu+100,0%
Massar Capital Management, LP39,000039,0001,275,300Neu+100,0%
Crossmark Global Holdings, Inc.32,977032,9771,078,347Neu+100,0%
Monaco Asset Management SAM32,520032,5201,063,404Neu+100,0%
BANK OF AMERICA CORP /DE/30,969030,9691,012,687Neu+100,0%
BAROMETER CAPITAL MANAGEMENT INC.37,100037,100883,722Neu+100,0%
AMERICAN CENTURY COMPANIES INC26,729026,729874,038Neu+100,0%
XTX Topco Ltd23,219023,219759,261Neu+100,0%
MOODY NATIONAL BANK TRUST DIVISION20,849020,849681,762Neu+100,0%
TWO SIGMA INVESTMENTS, LP16,360016,360534,972Neu+100,0%
Quadrature Capital Ltd15,006015,006490,696Neu+100,0%
Aquatic Capital Management LLC13,712013,712448,382Neu+100,0%
MARSHALL WACE, LLP11,200011,200366,240Neu+100,0%
GOLDMAN SACHS GROUP INC11,144011,144364,409Neu+100,0%
BNP PARIBAS FINANCIAL MARKETS11,098011,098362,905Neu+100,0%
COMMONWEALTH EQUITY SERVICES, LLC8,86108,861289,750Neu+100,0%
GEODE CAPITAL MANAGEMENT, LLC7,85107,851256,727Neu+100,0%
RHUMBLINE ADVISERS6,97206,972227,977Neu+100,0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP6,96806,968227,854Neu+100,0%
Ascent Group, LLC6,23706,237203,950Neu+100,0%
GROUP ONE TRADING LLC5,40005,400176,580Neu+100,0%
ROYAL BANK OF CANADA5,35505,355175,000Neu+100,0%
QUADRANT CAPITAL GROUP LLC3,52003,520115,104Neu+100,0%
China Universal Asset Management Co., Ltd.2,35602,35677,041Neu+100,0%
BARCLAYS PLC2,35502,35577,009Neu+100,0%
Arax Advisory Partners2,33502,33576,355Neu+100,0%
SIGNATUREFD, LLC1,64101,64153,661Neu+100,0%
GAMMA Investing LLC1,25001,25040,875Neu+100,0%
State of Wyoming1,22701,22740,123Neu+100,0%
SIMPLEX TRADING, LLC774077425,309Neu+100,0%
Tower Research Capital LLC (TRC)548054817,920Neu+100,0%
CITIGROUP INC404040413,211Neu+100,0%
Smartleaf Asset Management LLC389038912,685Neu+100,0%
OSAIC HOLDINGS, INC.370037012,099Neu+100,0%

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Fail-to-Deliver (6 Monate)

DatumFTD-MengeKursWert (USD)
2026-03-274029,971.199
2026-03-253.30629,8098.519
2026-03-1652031,7116.489

Top-Fondshalter

Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.

FondsAnteileWert (USD)Anteil (%)
GILEAD SCIENCES, INC.16,707,477550,616,29071.25
Madison Avenue Partners, LP2,213,16972,370,6269.36
AMERIPRISE FINANCIAL INC1,451,23947,455,5166.14
SEGALL BRYANT & HAMILL, LLC448,09614,652,7391.90
UBS Group AG349,44411,426,8191.48
MILLENNIUM MANAGEMENT LLC339,35411,096,8761.44
BlackRock, Inc.314,26910,276,5961.33
RENAISSANCE TECHNOLOGIES LLC310,60010,156,6201.31
D. E. Shaw & Co., Inc.274,9998,992,4671.16
Hudson Bay Capital Management LP170,0005,559,0000.72
DAFNA Capital Management LLC130,1754,256,7230.55
CITADEL ADVISORS LLC108,1963,538,0100.46
NORGES BANK90,0002,943,0000.38
MORGAN STANLEY68,2852,232,9210.29
FMR LLC56,9691,862,8870.24
Man Group plc47,5811,555,8990.20
VOLORIDGE INVESTMENT MANAGEMENT, LLC43,8561,434,0910.19
Massar Capital Management, LP39,0001,275,3000.17
Crossmark Global Holdings, Inc.32,9771,078,3470.14
Monaco Asset Management SAM32,5201,063,4040.14

Hinweis

Erweitert ×